| 1. Xun Li, Singh SM, Lourdusamy M, Merand Y, Veilleux R, Labrie F. (1995) Synthesis and in vitro antiandrogenic activity of 17-hydroxy-17-(-hydroxy/haloalkyn-1-yl)-4-methyl-4-aza-3-oxo-5-androstan-(1-ene)-3-ones, 5 (10): [10.1016/0960-894X(95)00166-Q] |
| 2. Li X, Singh SM, Labrie F.. (1995) Synthesis and in vitro activity of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5 alpha-androstan-3-ones as inhibitors of human 5 alpha-reductases and antagonists of the androgen receptor., 38 (7): [PMID:7707319] [10.1021/jm00007a013] |
| 3. Li X, Singh SM, Côté J, Laplante S, Veilleux R, Labrie F.. (1995) Synthesis and in vitro evaluation of 4-substituted N-(1,1-dimethylethyl)-3-oxo-4-androstene-17 beta-carboxamides as 5 alpha-reductase inhibitors and antiandrogens., 38 (9): [PMID:7739004] [10.1021/jm00009a006] |
| 4. Mallamo JP, Pilling GM, Wetzel JR, Kowalczyk PJ, Bell MR, Kullnig RK, Batzold FH, Juniewicz PE, Winneker RC, Luss HR.. (1992) Antiandrogenic steroidal sulfonyl heterocycles. Utility of electrostatic complementarity in defining bioisosteric sulfonyl heterocycles., 35 (10): [PMID:1588549] [10.1021/jm00088a001] |
| 5. Christiansen RG, Bell MR, D'Ambra TE, Mallamo JP, Herrmann JL, Ackerman JH, Opalka CJ, Kullnig RK, Winneker RC, Snyder BW.. (1990) Antiandrogenic steroidal sulfonylpyrazoles., 33 (8): [PMID:2374140] [10.1021/jm00170a008] |
| 6. Kong JW, Hamann LG, Ruppar DA, Edwards JP, Marschke KB, Jones TK.. (2000) Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro- and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quin olines., 10 (5): [PMID:10743937] [10.1016/s0960-894x(00)00010-x] |
| 7. Morris JJ, Hughes LR, Glen AT, Taylor PJ.. (1991) Non-steroidal antiandrogens. Design of novel compounds based on an infrared study of the dominant conformation and hydrogen-bonding properties of a series of anilide antiandrogens., 34 (1): [PMID:1992146] [10.1021/jm00105a067] |
| 8. Hamann LG, Higuchi RI, Zhi L, Edwards JP, Wang XN, Marschke KB, Kong JW, Farmer LJ, Jones TK.. (1998) Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines., 41 (4): [PMID:9484511] [10.1021/jm970699s] |
| 9. Salvati ME, Balog A, Wei DD, Pickering D, Attar RM, Geng J, Rizzo CA, Hunt JT, Gottardis MM, Weinmann R, Martinez R.. (2005) Identification of a novel class of androgen receptor antagonists based on the bicyclic-1H-isoindole-1,3(2H)-dione nucleus., 15 (2): [PMID:15603960] [10.1016/j.bmcl.2004.10.051] |
| 10. Salvati ME, Balog A, Shan W, Wei DD, Pickering D, Attar RM, Geng J, Rizzo CA, Gottardis MM, Weinmann R, Krystek SR, Sack J, An Y, Kish K.. (2005) Structure based approach to the design of bicyclic-1H-isoindole-1,3(2H)-dione based androgen receptor antagonists., 15 (2): [PMID:15603938] [10.1016/j.bmcl.2004.10.085] |
| 11. Parent EE, Dence CS, Jenks C, Sharp TL, Welch MJ, Katzenellenbogen JA.. (2007) Synthesis and biological evaluation of [18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo-thiobicalutamide as non-steroidal androgens for prostate cancer imaging., 50 (5): [PMID:17328524] [10.1021/jm060847r] |
| 12. Tachibana K, Imaoka I, Yoshino H, Emura T, Kodama H, Furuta Y, Kato N, Nakamura M, Ohta M, Taniguchi K, Ishikura N, Nagamuta M, Onuma E, Sato H.. (2007) Discovery of 7alpha-substituted dihydrotestosterones as androgen receptor pure antagonists and their structure-activity relationships., 15 (1): [PMID:17064916] [10.1016/j.bmc.2006.09.072] |
| 13. Roy J, Breton R, Martel C, Labrie F, Poirier D.. (2007) Chemical synthesis and biological activities of 16alpha-derivatives of 5alpha-androstane-3alpha,17beta-diol as antiandrogens., 15 (8): [PMID:17336533] [10.1016/j.bmc.2007.02.007] |
| 14. Tachibana K, Imaoka I, Yoshino H, Kato N, Nakamura M, Ohta M, Kawata H, Taniguchi K, Ishikura N, Nagamuta M, Onuma E, Sato H.. (2007) Discovery and structure-activity relationships of new steroidal compounds bearing a carboxy-terminal side chain as androgen receptor pure antagonists., 17 (20): [PMID:17804229] [10.1016/j.bmcl.2007.07.090] |
| 15. Salvati ME, Balog A, Shan W, Rampulla R, Giese S, Mitt T, Furch JA, Vite GD, Attar RM, Jure-Kunkel M, Geng J, Rizzo CA, Gottardis MM, Krystek SR, Gougoutas J, Galella MA, Obermeier M, Fura A, Chandrasena G.. (2008) Identification and optimization of a novel series of [2.2.1]-oxabicyclo imide-based androgen receptor antagonists., 18 (6): [PMID:18291644] [10.1016/j.bmcl.2008.02.006] |
| 16. Wakabayashi K, Imai K, Miyachi H, Hashimoto Y, Tanatani A.. (2008) 4-(Anilino)pyrrole-2-carboxamides: Novel non-steroidal/non-anilide type androgen antagonists effective upon human prostate tumor LNCaP cells with mutated nuclear androgen receptor., 16 (14): [PMID:18571420] [10.1016/j.bmc.2008.05.063] |
| 17. Ohta K, Goto T, Fijii S, Suzuki T, Ohta S, Endo Y.. (2008) Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring., 16 (17): [PMID:18707892] [10.1016/j.bmc.2008.07.055] |
| 18. Bydal P, Luu-The V, Labrie F, Poirier D.. (2009) Steroidal lactones as inhibitors of 17beta-hydroxysteroid dehydrogenase type 5: chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities., 44 (2): [PMID:18472187] [10.1016/j.ejmech.2008.03.020] |
| 19. Zhou J, Geng G, Shi Q, Sauriol F, Wu JH.. (2009) Design and synthesis of androgen receptor antagonists with bulky side chains for overcoming antiandrogen resistance., 52 (17): [PMID:19725582] [10.1021/jm801218k] |
| 20. Schlienger N, Lund BW, Pawlas J, Badalassi F, Bertozzi F, Lewinsky R, Fejzic A, Thygesen MB, Tabatabaei A, Bradley SR, Gardell LR, Piu F, Olsson R.. (2009) Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators., 52 (22): [PMID:19856921] [10.1021/jm901149c] |
| 21. Roll DM, Barbieri LR, Bigelis R, McDonald LA, Arias DA, Chang LP, Singh MP, Luckman SW, Berrodin TJ, Yudt MR.. (2009) The lecanindoles, nonsteroidal progestins from the terrestrial fungus Verticillium lecanii 6144., 72 (11): [PMID:19863083] [10.1021/np9004882] |
| 22. Bellavance E, Luu-The V, Poirier D.. (2009) Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone., 52 (23): [PMID:19772289] [10.1021/jm900921c] |
| 23. Goto T, Ohta K, Fujii S, Ohta S, Endo Y.. (2010) Design and synthesis of androgen receptor full antagonists bearing a p-carborane cage: promising ligands for anti-androgen withdrawal syndrome., 53 (13): [PMID:20521823] [10.1021/jm100316f] |
| 24. PubChem BioAssay data set, |
| 25. PubChem BioAssay data set, |
| 26. Maltais R, Fournier MA, Poirier D.. (2011) Development of 3-substituted-androsterone derivatives as potent inhibitors of 17β-hydroxysteroid dehydrogenase type 3., 19 (15): [PMID:21741247] [10.1016/j.bmc.2011.06.003] |
| 27. Poutiainen PK, Oravilahti T, Peräkylä M, Palvimo JJ, Ihalainen JA, Laatikainen R, Pulkkinen JT.. (2012) Design, synthesis, and biological evaluation of nonsteroidal cycloalkane[d]isoxazole-containing androgen receptor modulators., 55 (14): [PMID:22746350] [10.1021/jm300233k] |
| 28. Nakamura M, Makishima M, Hashimoto Y.. (2013) Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange., 21 (7): [PMID:23462715] [10.1016/j.bmc.2013.01.060] |
| 29. Yamada A, Fujii S, Mori S, Kagechika H.. (2013) Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists., 4 (10): [PMID:24900588] [10.1021/ml4001744] |
| 30. PubChem BioAssay data set, |
| 31. PubChem BioAssay data set, |
| 32. PubChem BioAssay data set, |
| 33. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds, [10.6019/CHEMBL3301361] |
| 34. Inoue K, Urushibara K, Kanai M, Yura K, Fujii S, Ishigami-Yuasa M, Hashimoto Y, Mori S, Kawachi E, Matsumura M, Hirano T, Kagechika H, Tanatani A.. (2015) Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists., 102 [PMID:26295173] [10.1016/j.ejmech.2015.08.002] |
| 35. Anjum S, Swan SK, Lambrecht LJ, Radwanski E, Cutler DL, Affrime MB, Halstenson CE.. (1999) Pharmacokinetics of flutamide in patients with renal insufficiency., 47 (1): [PMID:10073738] [10.1046/j.1365-2125.1999.00831.x] |
| 36. Kinoshita M, Negishi M, Sakai H, Hirano T, Mori S, Fujii S, Kagechika H, Tanatani A.. (2016) Development of 6-arylcoumarins as nonsteroidal progesterone antagonists. Structure-activity relationships and fluorescence properties., 24 (21): [PMID:27665178] [10.1016/j.bmc.2016.09.020] |
| 37. He Y, Wu M, Liu Y, Li Q, Li X, Hu L, Cen S, Zhou J.. (2016) Identification of Triptophenolide from Tripterygium wilfordii as a Pan-antagonist of Androgen Receptor., 7 (12): [PMID:27994731] [10.1021/acsmedchemlett.6b00180] |
| 38. Unpublished dataset, |
| 39. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
| 40. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
| 41. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
| 42. Endo S, Oguri H, Segawa J, Kawai M, Hu D, Xia S, Okada T, Irie K, Fujii S, Gouda H, Iguchi K, Matsukawa T, Fujimoto N, Nakayama T, Toyooka N, Matsunaga T, Ikari A.. (2020) Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate Cancer., 63 (18): [PMID:32847363] [10.1021/acs.jmedchem.0c00939] |
| 43. Unpublished dataset, |
| 44. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 45. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
| 46. Xiang W, Wang S.. (2022) Therapeutic Strategies to Target the Androgen Receptor., 65 (13.0): [PMID:35786895] [10.1021/acs.jmedchem.2c00716] |
